GUANGZHOU, China — June 24, 2026 — China Alliance of Research in High-Myopia (CHARM) Guangdong Provincial Sub-Center was officially inaugurated on June 23 at a launch event in Guangzhou, marking the alliance's first provincial-level expansion. The new center is spearheaded by Guangzhou First People's Hospital, with core technological partner from EVisionAI and WISER Optomed 欧视医疗 — the China joint venture between Finland-listed Optomed Plc (HEL: OPTOMED) and WISER. The launch

First-of-its-kind initiative brings clinical-grade eye health diagnostics to China's optical retail sector, with integrated referral pathways to top-tier hospitals GUANGZHOU, China — June 2026 — WISER ASIA, a China-based venture development and market-entry firm focused on European medtech, today announced that its portfolio company WISER Optomed Medical has launched an AI-powered fundus screening program in partnership with Oriental Vision, one of China's most established op

Recently, Petri Salonen, Chairman of Optomed, and Vuokko, Head of Technology, led core colleagues from the local operations, product and support teams to conduct an on-site inspection of the AI fundus screening pilot project in Guangzhou. The project is operated by Wiser Optomed Medical Technologies Co., Ltd., the joint venture between Optomed and Wiser in China, and is being implemented at multiple primary medical institutions in Liwan District, Guangzhou. As a key practice

Guangzhou, March 20, 2026 – Kevin, CEO of Wiser Asia (Wiser), together with representatives from its partners – Swiss-based Falco Global Partners and Yuekai Securities – paid an official visit to WeRide (https://www.weride.ai), a leading autonomous driving solution provider in China based in Guangzhou. The joint visit, initiated by Wiser and its partners, aimed to deepen mutual understanding with WeRide, explore potential overseas cooperation opportunities, and jointly advanc

Guangdong, China – December 16, 2025 – Wiser Optomed Medical Technologies (“Wiser Optomed”), a joint venture between Wiser and Optomed, announced today that its AI-powered retinal screening solution has been awarded Third Prize in the AI+Eye Health track at the inaugural Global Technology Innovation Competition. Hosted under the theme “Global Innovation, Empowerment in Zhejiang,” the competition focused on four cutting-edge sectors: humanoid robotics, biotech, AI+eye health,

This week, Mr. Kevin CHEN, CEO of WISER, together with our partners Mr. Ferdinando "Nani" Falco Beccalli and Ms. Patricia Falco Beccalli (Szarvas) of Falco Global Partners, attended the 2025 Hong Kong AVCJ Private Equity Forum. Held at the Four Seasons Hotel Hong Kong, the delegation took advantage of this high-end platform to deeply connect with top Asian capital resources, accurately explore high-quality investment opportunities in the Chinese and overseas markets, and furt